Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Sell
70,348
-5,895
-8% -$1.06M 0.28% 71
2025
Q4
$14.1M Buy
76,243
+13,214
+21% +$2.47M 0.3% 59
2025
Q3
$12.7M Buy
63,029
+842
+1% +$173K 0.4% 48
2025
Q2
$13.6M Buy
62,187
+34,061
+121% +$7.69M 0.43% 47
2025
Q1
$6.86M Buy
28,126
+1,984
+8% +$450K 0.51% 38
2024
Q4
$5.55M Buy
26,142
+24,570
+1,563% +$5.45M 0.35% 52
2024
Q3
$351K Buy
1,572
+194
+14% +$43.1K 0.06% 129
2024
Q2
$290K Buy
+1,378
New +$283K 0.06% 123
2023
Q2
Sell
-1,374
Closed -$229K 141
2023
Q1
$229K Buy
+1,374
New +$229K 0.06% 147

Other funds holding MRSH

Callan Family Office's MRSH Position: Q1 2026 in Review

Callan Family Office reduced its Marsh (MRSH) stake by 7.7% in Q1 2026, selling an estimated $1.06M and leaving 70,348 shares worth $12.2M. The position accounts for 0.28% of the portfolio, ranked #71.

Callan Family Office first reported a position in MRSH in Q1 2023 and has held it in 9 quarters since. The position peaked at $14.1M in Q4 2025. 1,534 funds tracked by Wall St. Rank hold MRSH as of Q1 2026.

  • Callan Family Office held 70,348 shares of Marsh worth $12.2M as of Q1 2026.
  • Callan Family Office sold 5,895 Marsh shares in Q1 2026, an estimated $1.06M.
  • Marsh made up 0.28% of Callan Family Office's portfolio in Q1 2026, its #71 holding.
  • Callan Family Office first reported a position in Marsh in Q1 2023 and has held it in 9 quarters since.
  • Callan Family Office's Marsh position peaked at $14.1M in Q4 2025.
  • 1,534 funds tracked by Wall St. Rank held Marsh as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.